CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Biotechnology

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Comment by Nastroon Apr 05, 2019 2:27am

73 Views

Post# 29585891

RE:Approval period

Looney I believe that the average length of time for approval for a de novo application is 133 days which would make it next month some time. However, that is the average so could be before then as well, conceivably even this month sometime.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property